Sensex Today | Stock Market LIVE Updates: Eternal in focus as Citi raises target price, banks on Blinkit's growth
Published on 09/10/2025 07:46 AM
Company to invest US$250 million over five years to set up a new respiratory manufacturing facility in the United States
Additional facility will help de-risk Lupin’s complex inhaler pipeline, a key segment for the company
US investment may mitigate geopolitical risks such as tariffs, supported by the Trump administration’s recent softer stance on investment announcements